Barchart.com
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Immatics NV (IMTX)

Immatics NV (IMTX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.63 -0.08 (-1.70%) 03/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.60 -0.03 (-0.65%) 17:39 ET
News & Headlines for Fri, Mar 28th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
New Strong Buy Stocks for February 12th
New Strong Buy Stocks for February 12th Zacks Investment Research - Wed Feb 12, 6:48AM CST

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Bank of Hawaii Corporation BOH: This bank holding company for Bank of Hawaii has seen the Zacks Consensus Estimate for its current...

RH : 236.28 (-2.93%)
BHRB : 55.97 (-2.20%)
BOH : 68.55 (-1.78%)
IMTX : 4.63 (-1.70%)
AUB : 30.68 (-3.16%)
Immatics N.V. Reports Promising Clinical Data for TCR Bispecific Molecules and Advances Four Cancer Therapy Candidates Quiver Quantitative, Inc. - Mon Nov 18, 2024

Immatics targets five cancer types with TCR-T therapies; recent data shows promising results for TCER® IMA402 and ACTengine® IMA203.Quiver AI SummaryImmatics N.V. announced a strategic expansion of its...

IMTX : 4.63 (-1.70%)
Immatics: Q3 Earnings Snapshot AP - Mon Nov 18, 2024

Immatics: Q3 Earnings Snapshot

IMTX : 4.63 (-1.70%)
Immatics: Q2 Earnings Snapshot AP - Tue Aug 13, 2024

Immatics: Q2 Earnings Snapshot

IMTX : 4.63 (-1.70%)
Immatics: Q1 Earnings Snapshot AP - Tue May 14, 2024

Immatics: Q1 Earnings Snapshot

IMTX : 4.63 (-1.70%)
Immatics: Q3 Earnings Snapshot AP - Tue Nov 14, 2023

Immatics: Q3 Earnings Snapshot

IMTX : 4.63 (-1.70%)
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors PR Newswire - Tue Sep 12, 2023

/PRNewswire / Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...

IMTX : 4.63 (-1.70%)
PLX : 2.58 (unch)
Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics ACCESS Newswire - Mon Sep 11, 2023

Collaboration combines leading technologies to develop breakthrough, mRNA-enabled in vivo expressed TCER® molecules

IMTX : 4.63 (-1.70%)
MRNA : 31.12 (-3.11%)
Immatics: Q2 Earnings Snapshot AP - Thu Aug 17, 2023

Immatics: Q2 Earnings Snapshot

IMTX : 4.63 (-1.70%)
Immatics: Q1 Earnings Snapshot AP - Tue May 16, 2023

Immatics: Q1 Earnings Snapshot

IMTX : 4.63 (-1.70%)

Barchart Exclusives

Trump Tariffs, Tesla Deliveries and Other Key Things to Watch this Week Barchart - Sun Mar 30, 6:38PM CDT
The S&P 500 suffered more selling on Friday after a hot inflation report and weak consumer sentiment spooked investors. Here are 5 things to watch this week in the Market. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies
Wed, Apr 02, 2025 5:00 PM UTC
Reserve Your Spot